Send the following on WhatsApp
Continue to Chathttps://forschung.kssg.ch/en/projects/802-a-randomized-open-label-phase-iii-open-platform-study-evaluating-safety-and-efficacy-of-novel-ruxolitinib-combina-tions-in-myelofibrosis-patients
https://forschung.kssg.ch/en/projects/802-a-randomized-open-label-phase-iii-open-platform-study-evaluating-safety-and-efficacy-of-novel-ruxolitinib-combina-tions-in-myelofibrosis-patients